753 related articles for article (PubMed ID: 22370315)
41. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.
Schagen SB; Muller MJ; Boogerd W; Rosenbrand RM; van Rhijn D; Rodenhuis S; van Dam FS
Ann Oncol; 2002 Sep; 13(9):1387-97. PubMed ID: 12196364
[TBL] [Abstract][Full Text] [Related]
42. Effects of adjuvant treatment on cognitive function in women with early breast cancer.
Hedayati E; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
Eur J Oncol Nurs; 2012 Jul; 16(3):315-22. PubMed ID: 21908235
[TBL] [Abstract][Full Text] [Related]
43. Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer.
Appel JM; Zerahn B; Møller S; Christensen HM; Søgaard P; Ejlertsen B; Fogh-Andersen N; Jensen BV; Nielsen DL
Acta Oncol; 2012 Nov; 51(8):1054-61. PubMed ID: 22909389
[TBL] [Abstract][Full Text] [Related]
44. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study.
Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB
Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410
[TBL] [Abstract][Full Text] [Related]
45. Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience.
De Maio E; Gravina A; Pacilio C; Amabile G; Labonia V; Landi G; Nuzzo F; Rossi E; D'Aiuto G; Capasso I; Rinaldo M; Morrica B; Elmo M; Di Maio M; Perrone F; de Matteis A
BMC Cancer; 2005 Mar; 5():30. PubMed ID: 15790416
[TBL] [Abstract][Full Text] [Related]
46. Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
McCune JS; Games DM; Espirito JL
J Oncol Pharm Pract; 2005 Jun; 11(2):37-43. PubMed ID: 16460603
[TBL] [Abstract][Full Text] [Related]
47. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study.
Chen X; Zhu C; Li J; Qiu L; Zhang L; Yu F; Ye R; Zhang J; Wang K
Brain Res; 2013 Oct; 1533():63-72. PubMed ID: 23954744
[TBL] [Abstract][Full Text] [Related]
48. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
[TBL] [Abstract][Full Text] [Related]
49. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study.
van der Willik KD; Koppelmans V; Hauptmann M; Compter A; Ikram MA; Schagen SB
Breast Cancer Res; 2018 Nov; 20(1):135. PubMed ID: 30442190
[TBL] [Abstract][Full Text] [Related]
50. Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy.
Koppelmans V; de Groot M; de Ruiter MB; Boogerd W; Seynaeve C; Vernooij MW; Niessen WJ; Schagen SB; Breteler MM
Hum Brain Mapp; 2014 Mar; 35(3):889-99. PubMed ID: 23281152
[TBL] [Abstract][Full Text] [Related]
51. Chemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients.
Saarto T; Blomqvist C; Välimäki M; Mäkelä P; Sarna S; Elomaa I
J Clin Oncol; 1997 Apr; 15(4):1341-7. PubMed ID: 9193325
[TBL] [Abstract][Full Text] [Related]
52. Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study.
Hermelink K; Untch M; Lux MP; Kreienberg R; Beck T; Bauerfeind I; Münzel K
Cancer; 2007 May; 109(9):1905-13. PubMed ID: 17351951
[TBL] [Abstract][Full Text] [Related]
53. Cognitive function in women with breast cancer receiving adjuvant chemotherapy and healthy controls.
Ando-Tanabe N; Iwamitsu Y; Kuranami M; Okazaki S; Yasuda H; Nakatani Y; Yamamoto K; Watanabe M; Miyaoka H
Breast Cancer; 2014 Jul; 21(4):453-62. PubMed ID: 22976288
[TBL] [Abstract][Full Text] [Related]
54. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.
Ahles TA; Saykin AJ; Furstenberg CT; Cole B; Mott LA; Skalla K; Whedon MB; Bivens S; Mitchell T; Greenberg ER; Silberfarb PM
J Clin Oncol; 2002 Jan; 20(2):485-93. PubMed ID: 11786578
[TBL] [Abstract][Full Text] [Related]
55. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.
Chen X; Li J; Ren J; Hu X; Zhu C; Tian Y; Hu P; Ma H; Yu F; Wang K
Psychooncology; 2014 Oct; 23(10):1165-71. PubMed ID: 24737580
[TBL] [Abstract][Full Text] [Related]
56. Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy.
de Jong N; Candel MJ; Schouten HC; Abu-Saad HH; Courtens AM
Ann Oncol; 2004 Jun; 15(6):896-905. PubMed ID: 15151946
[TBL] [Abstract][Full Text] [Related]
57. Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.
Hurria A; Hurria A; Brogan K; Panageas KS; Pearce C; Norton L; Jakubowski A; Howard J; Hudis C
Drugs Aging; 2005; 22(9):785-91. PubMed ID: 16156682
[TBL] [Abstract][Full Text] [Related]
58. Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer.
Boele FW; Schilder CM; de Roode ML; Deijen JB; Schagen SB
Menopause; 2015 Jan; 22(1):17-25. PubMed ID: 24977455
[TBL] [Abstract][Full Text] [Related]
59. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
60. Weight gain in women with breast cancer treated with adjuvant cyclophosphomide, methotrexate and 5-fluorouracil. Analysis of resting energy expenditure and body composition.
Del Rio G; Zironi S; Valeriani L; Menozzi R; Bondi M; Bertolini M; Piccinini L; Banzi MC; Federico M
Breast Cancer Res Treat; 2002 Jun; 73(3):267-73. PubMed ID: 12160332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
